Cate RL - Search Results

1

Directed expression of an oncogene to Sertoli cells in transgenic mice using mullerian inhibiting substance regulatory sequences.

Peschon JJ, Behringer RR, Cate RL, Harwood KA, Idzerda RL, Brinster RL, Palmiter RD. Peschon JJ, et al. Among authors: cate rl. Mol Endocrinol. 1992 Sep;6(9):1403-11. doi: 10.1210/mend.6.9.1331774. Mol Endocrinol. 1992. PMID: 1331774

2

Müllerian-inhibiting substance function during mammalian sexual development.

Behringer RR, Finegold MJ, Cate RL. Behringer RR, et al. Among authors: cate rl. Cell. 1994 Nov 4;79(3):415-25. doi: 10.1016/0092-8674(94)90251-8. Cell. 1994. PMID: 7954809

3

Abnormal sexual development in transgenic mice chronically expressing müllerian inhibiting substance.

Behringer RR, Cate RL, Froelick GJ, Palmiter RD, Brinster RL. Behringer RR, et al. Among authors: cate rl. Nature. 1990 May 10;345(6271):167-70. doi: 10.1038/345167a0. Nature. 1990. PMID: 2336108

4

Genetic analysis of the Müllerian-inhibiting substance signal transduction pathway in mammalian sexual differentiation.

Mishina Y, Rey R, Finegold MJ, Matzuk MM, Josso N, Cate RL, Behringer RR. Mishina Y, et al. Among authors: cate rl. Genes Dev. 1996 Oct 15;10(20):2577-87. doi: 10.1101/gad.10.20.2577. Genes Dev. 1996. PMID: 8895659 Free article.

5

Mullerian inhibiting substance requires its N-terminal domain for maintenance of biological activity, a novel finding within the transforming growth factor-beta superfamily.

Wilson CA, di Clemente N, Ehrenfels C, Pepinsky RB, Josso N, Vigier B, Cate RL. Wilson CA, et al. Among authors: cate rl. Mol Endocrinol. 1993 Feb;7(2):247-57. doi: 10.1210/mend.7.2.8469238. Mol Endocrinol. 1993. PMID: 8469238

6

Sequence, genomic organization, and chromosomal location of the mouse Müllerian-inhibiting substance type II receptor gene.

Mishina Y, Tizard R, Deng JM, Pathak BG, Copeland NG, Jenkins NA, Cate RL, Behringer RR. Mishina Y, et al. Among authors: cate rl. Biochem Biophys Res Commun. 1997 Aug 28;237(3):741-6. doi: 10.1006/bbrc.1997.7224. Biochem Biophys Res Commun. 1997. PMID: 9299437

7

Insensitivity of the chick embryo müllerian duct to human recombinant müllerian-inhibiting substance.

Weniger JP, Cate RL, Zeis A. Weniger JP, et al. Among authors: cate rl. J Mol Endocrinol. 1992 Feb;8(1):73-7. doi: 10.1677/jme.0.0080073. J Mol Endocrinol. 1992. PMID: 1543536

8

Cloning, expression, and alternative splicing of the receptor for anti-Müllerian hormone.

di Clemente N, Wilson C, Faure E, Boussin L, Carmillo P, Tizard R, Picard JY, Vigier B, Josso N, Cate R. di Clemente N, et al. Mol Endocrinol. 1994 Aug;8(8):1006-20. doi: 10.1210/mend.8.8.7997230. Mol Endocrinol. 1994. PMID: 7997230

9

Effect of anti-Mullerian hormone on Sertoli and Leydig cell functions in fetal and immature rats.

Rouiller-Fabre V, Carmona S, Merhi RA, Cate R, Habert R, Vigier B. Rouiller-Fabre V, et al. Endocrinology. 1998 Mar;139(3):1213-20. doi: 10.1210/endo.139.3.5785. Endocrinology. 1998. PMID: 9492056

10

Developmentally regulated polyadenylation of two discrete messenger ribonucleic acids for müllerian inhibiting substance.

Lee MM, Cate RL, Donahoe PK, Waneck GL. Lee MM, et al. Among authors: cate rl. Endocrinology. 1992 Feb;130(2):847-53. doi: 10.1210/endo.130.2.1346380. Endocrinology. 1992. PMID: 1346380

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

70 results

Search Page

Filters